NEW YORK, Dec. 8, 2016 /PRNewswire/ -- OTC Markets
Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000
U.S. and global securities, today announced Mateon Therapeutics,
Inc. (OTCQX: MATN), a biopharmaceutical company developing vascular
disrupting agents for the treatment of cancer, has qualified to
trade on the OTCQX® Best Market. Mateon Therapeutics
previously traded on NASDAQ.
Mateon Therapeutics begins trading today on OTCQX under the
symbol "MATN." U.S. investors can find current financial
disclosure and Real-Time Level 2 quotes for the company on
www.otcmarkets.com.
"Trading on OTCQX will allow Mateon Therapeutics to continue to
provide an efficient and transparent public trading market for its
investors while lowering the cost and complexity of being a public
company," said Jason Paltrowitz,
Executive Vice President of Corporate Services at OTC Markets
Group. "We look forward to supporting Mateon Therapeutics and its
shareholders."
Mateon Therapeutics, Inc. is a biopharmaceutical company seeking
to realize the full potential of vascular targeted therapy (VTT) in
oncology. VTT includes vascular disrupting agents (VDAs) such as
the investigational drugs that Mateon is developing, and
anti-angiogenic agents (AAs), a number of which are FDA-approved
and widely used in cancer treatment. These two approaches have
distinct yet complementary mechanisms of action.
About OTC Markets Group Inc.
OTC Markets Group Inc. (OTCQX: OTCM) operates the OTCQX® Best
Market, the OTCQB® Venture Market, and the Pink® Open Market for
10,000 U.S. and global securities. Through OTC Link® ATS, we
connect a diverse network of broker-dealers that provide liquidity
and execution services. We enable investors to easily trade
through the broker of their choice and empower companies to improve
the quality of information available for investors.
To learn more about how we create better informed and more
efficient markets, visit www.otcmarkets.com
OTC Link ATS is operated by OTC Link LLC, member FINRA/SIPC and
SEC regulated ATS.
Subscribe to the OTC Markets RSS Feed
Media Contact:
OTC Markets Group Inc., +1 (212) 896-4428, media@otcmarkets.com
Logo -
http://photos.prnewswire.com/prnh/20110118/MM31963LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/otc-markets-group-welcomes-mateon-therapeutics-to-otcqx-300374854.html
SOURCE OTC Markets Group Inc.